약동산업

비상장계속사업자

YAK DONG IND.

권흥석

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

약동산업

Business Reg. No. 6078134877 · CEO 권흥석

I.Investment Overview

Target약동산업 (6078134877)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명약동산업
영문명YAK DONG IND.
대표자권흥석
사업자등록번호6078134877
법인등록번호1801110162379
설립일1994.09.01

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW777.220211,264.820221,321.320231,191.620241,421.32025
영업이익100M KRW52.6202117.9202252202310.4202448.42025
순이익100M KRW46.6202115.520223920235.82024452025
Item20252024202320222021
자산총계813.8억원862.9억원942.8억원893억원882.5억원
부채총계259.2억원353.1억원438.8억원427.9억원430.9억원
자본총계554.6억원509.8억원504억원465억원451.6억원
매출액1,421.3억원1,191.6억원1,321.3억원1,264.8억원777.2억원
영업이익48.4억원10.4억원52억원17.9억원52.6억원
순이익45억원5.8억원39억원15.5억원46.6억원

VI.Financial Ratios

FY2025 basis

3.41%

영업이익률

3.16%

순이익률

5.52%

ROA

8.11%

ROE

46.74%

부채비율

68.15%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

약동산업 투심보고서 | Alpha Lenz